Ceftriaxone - Injection products
Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
| Minimum Inhibitory Concentrations | Disk Diffusion | ||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacteriaceae | M100 standard is recognized | |||||
Haemophilus influenzae and | M100 standard is recognized | |||||
Neisseria gonorrhoeae | M100 standard is recognized | |||||
Streptococcus pneumoniae | M100 standard is recognized | - | - | - | ||
Streptococcus pneumoniae | M100 standard is recognized | - | - | - | ||
Streptococcus spp β- Hemolytic Group | M100 standard is recognized | |||||
Streptococcus spp Viridans Group | M100 standard is recognized | |||||
Neisseria meningitidis | M100 standard is recognized | |||||
Anaerobes | ≤1 | 2 | ≥4 | - | - | - |
S = Susceptible; I = Intermediate; R = Resistan
Susceptibility interpretive criteria recognized for Enterobacteriaceae are based on a dose of 1 gram IV q 24h. For isolates with intermediate susceptibility, use a dose of 2 grams IV q 24h in patients with normal renal function.
For Haemophilus influenzae and parainfluenzae, susceptibility interpretive criteria recognized in CLSI M100 are based on a dose of 2 grams IV every 24 hours in patients with normal renal function.
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp
Other Non-Enterobacteriaceae